rss
Br J Ophthalmol 2000;84:506-511 doi:10.1136/bjo.84.5.506
  • Original Article
    • Clinical science

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study

  1. Chee H Kona,
  2. Riaz H Y Asariaa,
  3. Nicholas L Occlestonb,
  4. Peng T Khawa,
  5. George W Aylwarda
  1. aVitreoretinal and Glaucoma Units, Moorfields Eye Hospital, and Wound Healing Research Unit, Department of Pathology, Institute of Ophthalmology, London, bPfizer Central Research Unit, Sandwich, Kent
  1. Mr C H Kon, Wound Healing Research Unit, Department of Pathology, Institute of Ophthalmology, 11–43 Bath Street, London EC1V 9EL chee{at}private.nethead.co.uk
  • Accepted 13 January 2000

Abstract

AIM To assess clinical variables and vitreous protein as risk factors for the development of postoperative proliferative vitreoretinopathy (PVR).

METHODS A prospective study was conducted on 140 patients with a rhegmatogenous retinal detachment in whom a primary vitrectomy was performed. 12 clinical variables were recorded and vitreous samples obtained for measurement of protein concentration. Univariate and multivariate logistic regression analysis was used to determine the risk factors for PVR.

RESULTS Complete data were available for 136 of 140 patients. 40 of the 136 patients (29.4%) developed postoperative PVR. Univariate regression revealed that significant (p<0.05) risk factors included aphakia, presence of preoperative PVR, size of detachment, the use of silicone oil, and high vitreous protein level. Multivariate regression analysis revealed only aphakia (odds ratio 2.72), the presence of preoperative PVR (odds ratio 3.01), and high vitreous protein concentration (odds ratio 1.11) to be significant (p<0.05) independent, predictive risk factors for the development of PVR.

CONCLUSIONS This study has shown that the significant risk factors for PVR are preoperative PVR, aphakia, and high vitreous protein levels. Two models (clinical factors only and clinical factors and vitreous protein) were constructed to predict the probability of developing postoperative PVR and may be used to identify those at risk for possible intravitreal pharmacological treatment.

Footnotes

    Register for free content


    Free trial
    Individuals may register for a free 60 day online trial to all content.

    Free archive
    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.